Abstract Large scale international multicentre studies require sophisticated quality management for the collection, processing and logistics of biological samples to ensure a maximum degree of standardisation across different environmental conditions and settings. This paper describes a quality management system for the collection of biological samples (QMS-BS) which was applied during IDEFICS, a large European multicentre study. The application was evaluated by several criteria like response rates for the different types of biological samples, measures of sample quality, compliance with the QMS-BS and efficiency of the document and sample control and of the quality assurance system. Response rates varied from 56.6% for venous blood collection to 90.1% for saliva collection. All sample types were associated with problems of sample quality (e.g. haemolysis of blood samples, lack of cooling for urine samples or desiccation of saliva samples). Overall compliance with the QMS-BS was good, with some exceptions mainly related to sample control.
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In conclusion the QMS-BS is a valuable tool for the management of biological sample collection in epidemiological multicentre studies.
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Introduction
In epidemiological studies, biological samples have become an indispensable source of information [1] . Different sample types are used to measure a broad range of biomarkers, for example hormones, lipids, glucose, protein, bulk and trace elements or genetic factors. In epidemiology these are used to determine exposure, susceptibility or effects [2] . Several factors influence the observed concentration of a biomarker in the human body, some are inherent like age or sex, but others are controllable. These can affect the concentration of a biomarker either before, during or after sample collection. Before sample collection, fasting status, medication, drug intake, physical activity and diurnal and seasonal variation play an important role. For example glucose and fatty acids are known to be closely related to food intake and therefore fasting measurements are mostly used in epidemiological studies. The levels of most biomarkers vary during the day; some can even change considerably within minutes. Salivary morning cortisol for instance was found to change by approx. 10% within 30 min in adolescents [3] . Deacon et al. [4] reported the effects of posture on melatonin concentrations in plasma and saliva. After sample collection, other variables affect the stability of a biomarker in vitro, e.g. temperature, time until processing or freezing and additives like anticoagulants or stabilising agents. As one example, stability tests for fatty acids showed that these are very unstable at room temperature without any treatment [5] . All of these factors are potential sources of bias, and thus require to be standardised. The most important influences on biological samples are summarised in Table 1 . A comprehensive summary of factors influencing the quality of biological samples in molecular epidemiological studies is given in a review by Holland et al. [6] .
The standardised collection of biological samples in epidemiological studies is a challenging task, especially in international multicentre studies. Environmental conditions, such as ambient temperature, distance between field study centres and laboratories, may largely vary thus affecting the quality of the biological samples. Nevertheless, if data ought to be suitable for joint data analysis, standardised collection, processing, shipment, storage and analyses of biological samples is indispensable. A reliable quality management system can ensure standardisation across different environmental conditions and settings.
The International Organization for Standardization (ISO) created their quality management system (QMS) standards in 1987. These are applicable in different types of industries, for different types of activities or processes, e.g. design, production or service delivery. The ISO QMS standards certify processes, not the product itself. The standards are regularly reviewed by the ISO, the last revision was done in 2008 and the series was called ISO 9001:2008 series [7] .
Since the 1990s, the International Epidemiological Association (IEA) and many national associations have discussed quality criteria for epidemiological research. They have agreed on guidelines for Good Epidemiological Practice (GEP) which can be found on their respective websites [8] . All of these guidelines promote the idea of quality assurance in epidemiological studies, which was elaborated by Rajaraman and Samet [9] . A working group of the Department of Epidemiology at the INRS in France successfully implemented the ISO 9002 system in their department [10] . Their certified quality system includes procedures specific to the conduct of epidemiological studies in occupational epidemiology but detailed aspects of biomarker collection are not addressed by their quality system. An overview of quality aspects in molecular epidemiology was provided by Holland et al. [11] .
Considering the work of Moulin et al. [10] and Holland et al. [11] , we present a newly developed quality management system designed for the collection of biological samples in epidemiological studies (QMS-BS). The applicability of the QMS-BS was evaluated in the context of the IDEFICS study, a large European multi-centre study on childhood obesity, where several types of biological samples were collected. To evaluate the application of the QMS-BS, the following criteria were applied: sample Sterility response rates, measures of sample quality, compliance with the QMS-BS and efficiency of the document and sample control and of the quality assurance system.
Methods
Quality management system for biological samples (QMS-BS)
The conduct of an epidemiological study is suitable for the implementation of an ISO standard as shown by Moulin et al. [10] . Table 2 shows the embedding of the newly developed quality management system for the collection of biological samples (QMS-BS) into the ISO system, in analogy to the quality system for occupational epidemiology by Moulin. The key elements of the QMS-BS are described below.
Standard operating procedures (SOPs)
In clinical research, SOPs are defined as ''detailed written instructions to achieve uniformity of the performance of a specific function'' [12] . The QMS-BS foresees SOPs that are study-specific and have to be defined for each type of biological sample on the following aspects: For the QMS-BS an SOP template was developed (see Fig. 1 ) which also includes a document log to record changes to previous versions. SOPs have to be accessible to study personnel at any time during their work. In a multicentre study, if the study personnel do not have sufficient skill of English language, all SOPs must be translated to the native languages. Possible errors introduced by translation are minimised by back translation.
Document and sample control
Identification and tracing of biological samples requires appropriate labelling of each sample aliquot. ID-numbers given to study subjects and samples should be pseudonymised in a way that does not allow for the identification of the donor but still clearly defines the sample and enables its retrieval at any time.
Depending on the storage needs, ID-labels should be frost-resistant for down to -80°C or even suitable for storage in liquid nitrogen. An SOP has to address how labels are correctly attached to the biosample tubes, as samples with missing ID-labels will usually be excluded from the study. Coding of IDs in barcodes minimises reading mistakes and simplifies tracing of samples with the help of scanners. There are 1D, 2D or 3D barcode systems and radio-frequency identification (RFID) tags. The choice should depend on the amount of information that needs to be coded and the space available on the ID-stickers. 3D-labels are smallest and contain most information. RFID tags have read and write capabilities and can store up to 2 KB. If biological specimens are stored in a biobank for later analysis, a biosample database should be used for efficient retrieval and documentation of storage conditions. If all samples are used up for laboratory analysis, it might be more economic to use simple delivery notes.
Purchases and subcontracting
Uniform sampling equipment and consumables are important means of standardisation in a multicentre study. Use of standard materials can be assured by central purchasing, but additional management and shipping costs have to be accounted for. Alternatively, all materials have to be clearly defined for local purchase. In this case, feedback on the realisation of the requirements should be collected prior to study commencement. Several components of biological sample collection can be subject to subcontract, either if they cannot be accomplished by own personnel or as a means of standardisation to improve quality. Possible candidates for subcontracting are sample collection, processing or sample analysis. It has to be kept in mind that study elements which are subcontracted are usually more difficult to control by the study management concerning adherence to defined SOPs.
Process control
Before the beginning of the study, biological samples of interest must be identified along with all the steps for their collection, processing, storage, shipment and analyses. In a multicentre study there are two main options for sample processing: it can either be done locally, followed by freezing and shipping on dry ice or centrally, after shipping Provisions should be taken for each sample type regarding packaging, shipping intervals and delivery documentation. Shipment of biological samples requires a tracking system to follow packages and a notification by the sender before shipping to ensure that the recipient can accept the package and properly store the samples upon receipt. In the European Community, human biosamples are not generally considered as potentially infectious material any more [14, 15] . Dry ice used for shipping however, is subject to the dangerous goods regulations of the International Air Transport Association (IATA), which implies e.g. that only cargo planes are used for transportation.
SOPs for long-term storage of biological samples define storage temperatures, a system for sample retrieval, a surveillance system to detect equipment failures, an emergency plan, regular quality checks, and sample inventories.
Many laboratories have a QMS accredited according to ISO 15189. It is advisable to choose an accredited central laboratory to guarantee for uniform sample analysis. If shipment of samples from the survey centres to a central laboratory cannot be achieved within 48 h, transportation, even on dry ice, is not a safe option and decentral sample analysis should be preferred. Depending on the stability of the markers of interest there might be a need to analyse certain parameters directly upon collection (point-of-care analysis).
Quality assurance
According to ISO standards a set of activities should be introduced to ensure that the defined SOPs are implemented appropriately: This includes training activities and pretesting of all procedures. Internal and external quality audits should be conducted to verify adherence to the defined SOPs. All means and results of quality assurance have to be documented and should be comprehensible for the study personnel.
Application of the QMS-BS in the IDEFICS-study
IDEFICS is an Integrated Project in the 6th Framework Programme of the European Commission tackling the ''Identification and prevention of dietary-and lifestyleinduced health effects in children and infants''. A total of 16,188 pre-school and primary school children from eight European countries were examined during the baseline survey in 2007/2008. One major objective of the IDEFICS study was to assess the distribution of diet-and lifestylerelated health problems and to understand the causal pathways leading there. The main emphasis of the study was put on three disorders: obesity/overweight, insulin resistance and impaired bone health. Each of these health problems is associated with a set of biological markers or is even partly defined by them, as it is the case for insulin resistance. The background of the study, its research goals and instruments have been described elsewhere in detail [16, 17] .
Sample collection in the IDEFICS study was conducted according to the newly introduced QMS-BS (see Table 3 ). Children in the baseline survey were asked to donate fasting venous blood (native and EDTA blood), morning urine and saliva samples. If venous blood could not be obtained, capillary blood was taken where possible.
A set of SOPs was developed and translated to all survey languages describing the collection, processing, storage and shipping of all types of biological samples in detail.
Barcoded labels were used for sample tracking. Each biological sample was labelled with an unambiguous 10 digit identification number (ID) with the last two digits clearly defining the type of aliquot. A biosample database was developed to record detailed information on the preanalytical conditions (collection, processing and storage) of each sample (e.g. cryotube or vial) and its storage location (down to the position in the cryobox) so that retrieval of samples for further use or withdrawal of samples can be done easily. The database facilitates shipping of samples to the central laboratories by an automated generation of delivery notes. A central biobank of remaining samples was built up for long-term storage.
All sampling kits and processing material were purchased centrally. Biochemical analyses were carried out in a central laboratory accredited according to ISO 15189. DNA extraction, genotyping, RNA extraction and gene expression analysis were conducted at different central laboratories.
As blood lipids and blood glucose were markers of primary interest to assess the risk of study participants for metabolic syndrome, these were assessed on site by pointof-care analysis with the Cholestech LDX analyser [18] . The decision was made to use this relatively expensive method because it only uses one drop of venous or capillary blood; thus children who only agreed to give capillary blood could be included to maximize response rates for these key measures. The immediate feedback on these core variables also served as an incentive for the parents. Another drop of blood was sufficient for the fatty acid (FA) analysis of circulating lipids and was collected via a simple kit (Sigma-Aldrich cod. 11312-1KT). This method, developed by Marangoni et al. [19] , avoids the complex procedures for collection, storage, shipment, and sample preparation involved with the conventional method of FA analysis.
Apart from point-of-care analyses, all biomarkers were analysed by central laboratories. Markers analysed in blood samples comprised insulin, CRP and HbA1c, as well as Quality check on DNA yield and purity hormones of energy/fat metabolism and markers of bone metabolism. Markers analysed in morning urine included glucose, albumin, and creatinine, as well as several minerals and cortisol. An overview of all biological markers assessed during the IDEFICS study is given in Table 4 . PAX gene tubes containing an RNA stabilising agent were used to collect blood for gene expression analysis in a subsample of children [20] . In order to maximise response rates, sample collection of morning urine was performed at home by the parents, who received a collection kit and a detailed instruction sheet and DNA was obtained noninvasively from saliva samples. Collection procedures for saliva differed by the children's ability to spit the required amount of saliva: Oragene TM DNA collection kit OG 250 with saliva sponges were used for younger children who were usually not yet able to spit, Oragene TM DNA SelfCollection Kit OG 300 were used otherwise. The kits are user-friendly and provide a high amount of good quality DNA [21] . Samples of all types were processed at the local survey centres and shipped to central laboratories at regular intervals.
All procedures were instructed at a central training which was mandatory for all survey centres. The whole set of instruments was tested during a pretest (Suling, in preparation). During the survey, a central telephone hotline was established for all questions regarding the biological samples. Survey site visits were conducted by a central quality control unit where the practical field work was inspected and deviations from SOPs were corrected directly if possible, or else remedial actions were initiated.
Results

Evaluation of applied QMS-BS during the IDEFICS baseline survey
Response rates for different biological sample types in the eight survey centres are listed in Table 5 . Response rates varied for different types of biological samples with highest response rates for non-invasive sample types. Urine samples were obtained from 85.6% of the children in total, with the lowest response of 67.9% in centre 3. Saliva samples were collected from 90.2% of the children; again centre 3 had the lowest response rate of 76.7%. Two of the centres (centre 7 and 8) nearly reached completeness for this sample type. For blood sampling, it was attempted to collect venous blood; only children that were not willing to give venous blood were asked for capillary blood. In total, a remarkable 79.7% of the children gave capillary or venous blood and were thus eligible for point-of-care analysis. Centre 4 obtained a substantially lower rate than 
Genetic risk factors
Quality management for the collection of biological samples in multicentre studies 613 the other centres (61.6%). This centre also had some initial problems in obtaining fasting blood (7.3% of non-fasting blood samples compared to an average of 1.4%). Venous blood could be collected from on average 56.6% of children across all countries. Response rates for venous blood ranged from 51 to 83% between the centres with the exception of centre 3 where venous blood was only collected from 7.7% of the children. The site visit showed that the low response rate at centre 3 resulted from non-compliance with the study protocol: due to the specific situation in the study region children were primarily asked for capillary blood at the survey site and then given the additional opportunity for later venipuncture at another facility. As part of process control various measures of sample quality were recorded accompanying the different steps of sample collection and a quality check was performed for each sample in the laboratory upon arrival (see Table 6 ). Collection of morning urine was documented by the parents on a collection sheet; this included recording of potential problems with sample quality. About 2.9% of the parents reported that the sample was not the first morning urine, 3.9% that the children went to the toilet at night and 6.9% stated that the urine was left uncooled for several hours. These rates varied among the centres: for 45% of the urine samples of centre 4 at least one of these problems was reported compared to only 0.3% of centre 3. The quality check of urine samples at the central laboratory on the other hand generally showed no problems (data not shown).
Venous blood samples were repeatedly associated with several problems as noted both by the study centres in the biosample database and by the central laboratory. According to the study centres an average of 5.4% of the samples were haemolytic with a maximum prevalence of 25.1% in centre 1. The central laboratory on the other hand categorised 10.3% of samples as haemolytic, where again centre 1 was of main concern with 30.8% of samples classified as haemolytic. High amounts of haemolytic samples were also reported for centre 2, 4 and 8 (13.8, 8.2 and 12.1%, respectively). It can thus be concluded that the assessment of haemolytic samples by the study centres was not a suitable tool to detect problematic samples for laboratory analyses. Coagulation of EDTA samples occurred in 0.7% of the checked samples, most of which came from centre 4. All centres had occasional problems to reach the required filling quantity for the aliquots. In total 4% of the samples were considered to be 'short samples' by the central laboratory.
Saliva samples were least error-prone of all sample types; the small fraction of dry samples (0.7%) which arrived at the central laboratory (probably due to leakage) were re-hydrated and still extracted with a lower, but yet sufficient, yield of DNA.
Compliance with the QMS-BS varied between survey centres and components. All survey centres participated in the central training and conducted subsequent local trainings as foreseen in the quality assurance system. The survey centres implemented all standardised procedures according to SOPs as verified by the external quality audits during site visits. The only exception was the SOP for blood collection, were one centre (centre 3) did not follow the instructions to take venous blood preferentially as mentioned above. For some other components compliance was lower. Most notably, centres had difficulties using the biosample database. The software was considered to be too complex and data entry too time-consuming. This caused a delay in data entry which in turn resulted in problems in the central laboratory, where biochemical analyses could not be conducted for samples delivered without a corresponding database. Moreover, due to the delay it was not possible to carry out direct quality control of sample processing with the biosample database as initially planned. Variables recorded in the database like time intervals, e.g. between collection of blood samples and their centrifugation represent important measures of quality assurance.
As depicted in Table 6 especially one centre had problems to manage sample processing within the requested time span. 11.4% of the samples in centre 5 were centrifuged later than foreseen in the SOP, for all other centres this rate was below 1.5%. Problems with storage n/a n/a n/a n/a n/a n/a n/a n/a n/a Problems with storage n/a n/a n/a n/a n/a n/a n/a n/a n/a Problems with collection n/a n/a n/a n/a n/a n/a n/a n/a n/a Problems with processing n/a n/a n/a n/a n/a n/a n/a n/a n/a Discussion This paper introduces a quality management system for the collection of biological samples in epidemiological studies (QMS-BS). The QMS-BS was applied to a large multicentre study, the IDEFICS-study with the goal to collect biological samples of a standardised quality across all study centres and to build up a large biobank of blood, saliva and urine samples from children from different European regions. Evaluation showed that high average response rates were reached for all sample types. Similar rates were achieved during the German KIGGS study, a health study on children and adolescents, where a response rate of 85% was reached for urine samples in the 'Iodine Module' of the study [22] and 52.6% for an environmental survey module which included venous blood sampling amongst others [23] . Measures of sample quality revealed several problems which mainly occurred during sample collection and processing. Central purchase of consumables guaranteed comparability but was accompanied by high shipping costs; depending on the monetary value of the respective consumables up to 10% were added to their costs. Overall compliance with the QMS-BS was good in the study centres, although some exceptions were noted. These were related primarily to sample control. Study centres complained about the complexity of the biosample database, leading to a considerable delay in data entry. The database could thus not be used for quality control during the ongoing survey, only retrospectively. Nevertheless biobanking and sample retrieval would not have been possible without the biosample database. Generally, not all differences between centres could be avoided by the QMS-BS. In particular, blood response rates and sample quality differed substantially between centres. Different response rates for invasive sample types may be related to national characteristics, whereas differences in sample quality were probably rather based on different survey logistics, e.g. allocated manpower or geographical distances between sample collection and processing. The influence of sample quality on the analyses of biological makers in the IDEFICS-study will be the topic of future investigations.
It should be noted that the introduction of a quality management system is not able to solve all problems during sample collection in epidemiological studies. Another key aspect is the complexity of the applied procedures. Decisions made for user-friendly solutions within IDEFICS were generally expensive but very successful like e.g. point-of-care analysis of the main biological markers for metabolic syndrome (glucose, total cholesterol, HDL, triglycerides), DNA colletion with saliva kits that didn't need to be processed or cooled, and FA test strips that only needed one drop of blood for the analysis of complete fatty acid profiles. These solutions generally reached high response rates and offered a standardised quality. For example, because point-of-care analysis was employed for blood glucose and lipid analyses, response rates for the respective markers were increased by about 23% (representing the children which only agreed to the collection of capillary blood).
Results of the evaluation will contribute to further optimisation of biological sample collection for the IDE-FICS follow-up survey that starts in autumn 2009. The biosample database has been substantially simplified and a barcode scanner and laptop will be used for storage documentation. Moreover, procedures for serum collection will be changed to reduce the amount of haemolytic samples which was most likely caused by insufficient clotting times in combination with the completely native blood tubes that were used to allow for the removal of two drops of venous blood for point-of-care analysis and FA analysis before clotting started. To enhance compliance with the QMS-BS in the IDEFICS follow-up survey different options are currently discussed. Krockenberger et al. [24] investigated the adherence to SOPs in the context of clinical trials. They found that, for questions about the daily work, the staff was more likely to ask a colleague rather than to read the corresponding SOP (18.4 vs. 13.8%). The authors suggest a computer-based information retrieval system for SOPs to increase the ease-of-use and usefulness of SOPs wich might also be an interesting option for the QMS-BS. Other options are centralised re-training sessions and/or special emphasis on selected aspects of biological samples collection during the external site visits.
Practical aspects of field work and sample collection are often neglected in scientific exchange. The QMS-BS fills this gap and represents a systematic approach to sample collection for application in epidemiological studies. Over all its application in IDEFICS helped to obtain a high quality standard for the biological samples collection in this European multicentre study.
